SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77973.06
14.54 (0.02%)

Filter

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Emcure Pharmaceuticals Ltd.	Q V PT	31,472 Small Cap	1,657.25 (-0.17%)	42.94	8.48	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Wockhardt Ltd.	Q V+ PT	27,953 Small Cap	1,640 (-4.67%)	131.23	5.66	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Dr. Lal Pathlabs Ltd.	Q V PT	26,598 Small Cap	1,606.90 (1.28%)	52.34	10.76	13.05	17.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Ipca Laboratories Ltd.	Q V+ PT	39,672 Mid Cap	1,565.85 (0.14%)	49.27	5.14	8.87	4.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Aurobindo Pharma Ltd.	Q V+ PT	86,156 Mid Cap	1,480.50 (-0.20%)	40.43	3.91	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Eris Lifesciences Ltd.	Q V PT	19,001 Small Cap	1,380 (0.62%)	44.01	5.24	21.92	3.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Cipla Ltd.	Q V PT	1,10,283 Large Cap	1,371.70 (0.47%)	24.26	3.28	9.97	30.14	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Dr. Reddys Laboratories Ltd.	Q V PT	1,09,382 Mid Cap	1,306.75 (-0.29%)	19.64	2.94	13.26	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	3B Blackbio Dx Ltd.	Q V PT	1,129 Small Cap	1,300 (-1.22%)	22.1	3.63	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Rainbow Childrens Medicare Ltd.	Q V PT	13,045 Small Cap	1,295 (0.82%)	53.19	7.91	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Jupiter Life Line Hospitals Ltd.	Q V PT	8,208 Small Cap	1,255.15 (0.26%)	43.98	5.27	18.02	36.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Vijaya Diagnostic Centre Ltd.	Q V PT	11,500 Small Cap	1,209.70 (1.72%)	72.13	12.67	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Global Health Ltd.	Q V PT	31,764 Small Cap	1,206.80 (2.15%)	68.24	8.18	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Laurus Labs Ltd.	Q V+ PT	63,517 Mid Cap	1,205.20 (2.44%)	71.46	11.98	14.42	4.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Concord Biotech Ltd.	Q V PT	12,795 Small Cap	1,198.70 (-1.99%)	40.94	6.76	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Natco Pharma Ltd.	Q V PT	20,600 Small Cap	1,156 (0.51%)	13.23	2.34	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Alivus Life Sciences Ltd.	Q V+ PT	13,789 Small Cap	1,129.15 (0.51%)	25.36	4.36	9.20	6.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Strides Pharma Science Ltd.	Q V+ PT	10,127 Small Cap	1,108.95 (0.93%)	55.22	3.07	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Sai Life Sciences Ltd.	Q V+ PT	22,866 Small Cap	1,078.50 (0.00%)	69.53	9.52	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Novartis India Ltd.	Q V+ PT	2,594 Small Cap	1,071 (1.93%)	26.68	3.28	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Max Healthcare Institute Ltd.	Q V PT	98,852 Mid Cap	1,013.65 (-0.20%)	69.65	9.54	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Jubilant Pharmova Ltd.	Q V+ PT	15,214 Small Cap	972 (1.76%)	N/A	6.76	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Rubicon Research Ltd.	Q V+ PT	16,494 Small Cap	962.60 (-3.65%)	98.45	12.75	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Fortis Healthcare Ltd.	Q V+ PT	72,283 Mid Cap	950.25 (-0.75%)	443.08	7.85	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Zydus Lifesciences Ltd.	Q V PT	94,495 Mid Cap	939.65 (0.06%)	19.13	3.6	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Senores Pharmaceuticals Ltd.	Q V+ PT	4,229 Small Cap	928 (1.05%)	306.7	5.9	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Windlas Biotech Ltd.	Q V PT	1,822 Small Cap	864 (0.09%)	27.31	3.32	18.24	17.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Innova Captab Ltd.	Q V PT	5,010 Small Cap	863.90 (-1.32%)	62.9	5.72	20.74	22.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	7,923 Small Cap	825 (0.33%)	84.69	4.96	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Alembic Pharmaceuticals Ltd.	Q V+ PT	15,443 Small Cap	779.90 (-0.73%)	24.55	2.83	7.69	-8.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Indoco Remedies	259.50	13.84%
Piramal Pharma	184.85	11.96%
Nectar Lifesciences	13.21	6.88%
Guj. Kidney & Super	131.40	6.44%
Sun Pharma Adv. Res	165.45	5.35%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Wockhardt	1,640	-4.67%
Rubicon Research	962.60	-3.65%
Concord Biotech	1,198.70	-1.99%
Dr. Agarwals Health	449.25	-1.94%
Kwality Pharma	1,694	-1.85%

News about Top Pharma Companies in India

May, 2026

USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility

The inspection closed with seven observations

May, 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has enclosed a copy of press release dated May 6, 2026, titled ‘USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Aurobindo Pharma zooms after getting EIR for Telangana unit

The USFDA has classified the said facility as Voluntary Action Indicated

May, 2026

Aurobindo Pharma gets EIR for Telangana unit

The USFDA has classified the said facility as Voluntary Action Indicated

May, 2026

Aurobindo Pharma informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) inspected Aurobindo Pharma’s Unit-VII, an oral solid dosage manufacturing unit, situated at Special Economic Zone (Pharma), TSIIC, Green Industrial Park, Polepally Village, Jedcherla Mandal, Mahaboobnagar District, 509302, Telangana from January 28 to February 10, 2026. At the end of the inspection, a ‘Form 483’ was issued with a total of 9 observations. The Unit has now received Establishment Inspection Report (EIR) classifying the facility as ‘Voluntary Action Indicated’ (‘VAI’). FDA has concluded that this inspection is now closed.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Emcure Pharma - Quaterly Results

A fair growth of 14.83% in the revenue at Rs. 14677.03 millions was reported in the March 2026 quarter as compared to Rs. 12781.88 millions during year-ago period.Net profit surges 67.46% to Rs. 2336.97 millions from Rs. 1395.57 millions in the quarter ended March 2026.The company reported a good operating profit of 3985.94 millions compared to 2670.33 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	14677.03	12781.88	14.83	52431.88	43819.24	19.65	52431.88	43819.24	19.65
Other Income	269.39	223.96	20.28	2095.16	1188.07	76.35	2095.16	1188.07	76.35
PBIDT	3985.94	2670.33	49.27	13342.66	7656.44	74.27	13342.66	7656.44	74.27
Interest	368.67	240.69	53.17	1182.71	1129.62	4.70	1182.71	1129.62	4.70
PBDT	3693.06	2429.64	52.00	11909.24	6526.82	82.47	11909.24	6526.82	82.47
Depreciation	630.40	569.12	10.77	2467.33	2249.72	9.67	2467.33	2249.72	9.67
PBT	3062.66	1860.52	64.61	9441.91	4277.10	120.75	9441.91	4277.10	120.75
TAX	725.69	464.95	56.08	2112.32	1105.82	91.02	2112.32	1105.82	91.02
Deferred Tax	-62.93	-170.95	-63.19	-225.09	-21.25	959.25	-225.09	-21.25	959.25
PAT	2336.97	1395.57	67.46	7329.59	3171.28	131.12	7329.59	3171.28	131.12
Equity	1895.90	1894.83	0.06	1895.90	1894.83	0.06	1895.90	1894.83	0.06
PBIDTM(%)	27.16	20.89	29.99	25.45	17.47	45.64	25.45	17.47	45.64

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	55,876 Crore
2	Neuland Laboratories Ltd.	21,775 Crore
3	Astrazeneca Pharma India Ltd.	20,924 Crore
4	Apollo Hospitals Enterprise Ltd.	1,11,527 Crore
5	Divis Laboratories Ltd.	1,78,026 Crore
6	Kovai Medical Center & Hospital Ltd.	6,253 Crore
7	Alkem Laboratories Ltd.	66,240 Crore
8	Procter & Gamble Health Ltd.	8,854 Crore
9	Dr Agarwals Eye Hospital Ltd.	2,470 Crore
10	Pfizer Ltd.	21,876 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,670	55,876	36.66	12.74	25.65	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,383	1,47,478	64.91	16.23	36.68	26.68
Ajanta Pharma Ltd. (S)	Very Good	3,103	38,646	36.60	8.54	24.73	24.45
Lupin Ltd. (M)	Somewhat Good	2,464	1,11,668	24.04	5.37	14.31	20.83
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,205	63,517	92.14
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,373	66,987	68.93
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,144	34,370	42.38
Wockhardt Ltd. (S)	Not Good	1,640	27,953	39.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,383	1,47,478	33.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,144	34,370	47.25	8.81	29.84	17.81
Mankind Pharma Ltd. (M)	Very Good	2,356	97,506	57.24	6.11	34.36	14.65
Laurus Labs Ltd. (M)	Very Good	1,205	63,517	71.46	11.98	35.90	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	13.26
Ajanta Pharma Ltd. (S)	Very Good	3,103	38,646	36.60	8.54	24.73	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	940	94,495	19.13	3.60	11.92	30.57
Cipla Ltd. (L)	Very Good	1,372	1,10,283	24.26	3.28	14.63	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,837	4,43,973	40.67	5.47	22.24	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,307	1,09,382	19.64	2.94	11.80	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,144	34,370	47.25	8.81	29.84	19.45

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

USFDA concludes GMP surveillance inspection at Zydus Lifesciences’ Ahmedabad facility

Zydus Lifesciences informs about press release

Aurobindo Pharma zooms after getting EIR for Telangana unit

Aurobindo Pharma gets EIR for Telangana unit

Aurobindo Pharma informs about updates

Emcure Pharma - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.